凯普生物(300639.SZ)：上半年净亏损8959.14万元

Core Insights - The company reported a significant decline in revenue for the first half of 2025, with total revenue reaching 315 million yuan, representing a year-on-year decrease of 22.96% [1] - The net profit attributable to shareholders was negative, amounting to -89.59 million yuan, indicating financial challenges [1] - The net profit after deducting non-recurring gains and losses was also negative at -95.61 million yuan, reflecting ongoing operational difficulties [1] - The basic earnings per share were reported at -0.1400 yuan, further highlighting the company's financial struggles [1]